Bariatric surgery versus intensive medical therapy for diabetes [4]

New England Journal of Medicine

Volumn 371, Issue 7, 2014, Pages 681-682

  Bielefeldt, Klaus ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARIATRIC SURGERY; COMPARATIVE EFFECTIVENESS; COST BENEFIT ANALYSIS; DIABETIC OBESITY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INTENSIVE CARE; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURGICAL TECHNIQUE; FEMALE; GASTRECTOMY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; STOMACH BYPASS;

ANTIDIABETIC AGENT;

DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; GASTRIC BYPASS; HUMANS; HYPOGLYCEMIC AGENTS; MALE;

EID: 84906093804     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1407393     Document Type: Letter

References (4)

1. Finkelstein EA, Khavjou OA, Thompson H, et al. Obesity and severe obesity forecasts through 2030. Am J Prev Med 2012;42:563-70.
2. Kohn GP, Galanko JA, Overby DW, Farrell TM. Recent trends in bariatric surgery case volume in the United States. Surgery 2009;146:375-80.
3. Neovius M, Narbro K, Keating C, et al. Health care use during 20 years following bariatric surgery. JAMA 2012;308:1132-41.
4. Wagstaff DJ. Public health and food safety: a historical association. Public Health Rep 1986;101:624-31. (Pubitemid 17206268)